Carmen Parisio Selected Research

2,4-dinitrobenzenesulfonic acid

1/2022	Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence.
6/2020	Pomegranate Mesocarp against Colitis-Induced Visceral Pain in Rats: Effects of a Decoction and Its Fractions.
1/2020	Acute visceral pain relief mediated by A3AR agonists in rats: involvement of N-type voltage-gated calcium channels.
1/2020	Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carmen Parisio Research Topics

Disease

12	Pain (Aches) 04/2022 - 01/2019
8	Colitis 02/2022 - 12/2019
8	Visceral Pain 02/2022 - 12/2019
7	Hypersensitivity (Allergy) 04/2022 - 06/2019
6	Neuralgia (Stump Neuralgia) 01/2022 - 01/2019
4	Inflammation (Inflammations) 02/2022 - 01/2020
3	Abdominal Pain (Pain, Abdominal) 12/2020 - 01/2020
3	Rheumatoid Arthritis 01/2020 - 04/2019
2	Hyperalgesia 11/2021 - 10/2021
1	Tendinopathy (Tendonitis) 04/2022
1	Gliosis 02/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2022
1	Arthritis (Polyarthritis) 02/2022
1	Chronic Pain 02/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2020
1	Fibrosis (Cirrhosis) 12/2020
1	Constipation 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Pica (Geophagia) 01/2020
1	Vomiting 01/2020
1	Cognitive Dysfunction 01/2020
1	Sarcopenia 01/2020
1	Nausea 01/2020
1	Osteoarthritis 06/2019

Drug/Important Bio-Agent (IBA)

9	2,4-dinitrofluorobenzene sulfonic acidIBA 02/2022 - 12/2019
4	2,4-dinitrobenzenesulfonic acidIBA 01/2022 - 01/2020
3	Opioid Analgesics (Opioids)IBA 02/2022 - 01/2020
2	GlucosinolatesIBA 02/2022 - 01/2019
2	Sulfonic AcidsIBA 02/2022 - 01/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 10/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 01/2021
2	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2020
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2021 - 04/2019
2	Polysaccharides (Glycans)IBA 06/2020 - 12/2019
1	Collagen Type I (Type I Collagen)IBA 04/2022
1	Fibroins (Fibroin)IBA 04/2022
1	Collagenases (Collagenase)FDA Link 04/2022
1	Triamcinolone (Aristocort)FDA Link 04/2022
1	ScleroproteinsIBA 04/2022
1	CarrageenanIBA 04/2022
1	CollagenIBA 04/2022
1	2,4-dinitrobenzeneIBA 02/2022
1	Potassium Channels (Potassium Channel)IBA 02/2022
1	LipidsIBA 02/2022
1	palmidrolIBA 02/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	AlarminsIBA 01/2022
1	fluorocitrateIBA 11/2021
1	PoisonsIBA 11/2021
1	dinitrobenzenesulfonic acidIBA 11/2021
1	ElementsIBA 11/2021
1	Protein Isoforms (Isoforms)IBA 10/2021
1	Vincristine (Oncovin)FDA LinkGeneric 10/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2021
1	Antineoplastic Agents (Antineoplastics)IBA 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	D16F7IBA 10/2021
1	methyllycaconitineIBA 01/2021
1	DDD-028IBA 01/2021
1	Carbonic Anhydrase IVIBA 01/2021
1	MecamylamineIBA 01/2021
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Olive OilIBA 12/2020
1	Hematoxylin (Haematoxylon)IBA 12/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2020
1	C.I. direct red 80IBA 12/2020
1	ellagitanninIBA 06/2020
1	Hydrolyzable TanninsIBA 06/2020
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2020
1	Naltrexone (ReVia)FDA LinkGeneric 01/2020
1	Morphine (MS Contin)FDA LinkGeneric 01/2020
1	Thioctic Acid (Lipoic Acid)IBA 01/2020
1	Opioid Receptors (Opioid Receptor)IBA 01/2020
1	Calcium Channels (Calcium Channel)IBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2020
1	methyl butyrateIBA 01/2020
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2020
1	PolyphenolsIBA 12/2019
1	Pregabalin (Lyrica)FDA Link 06/2019
1	Freund's AdjuvantIBA 06/2019
1	Ibuprofen (Motrin)FDA LinkGeneric 06/2019
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2019
1	Cyclooxygenase InhibitorsIBA 04/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	glucoerucinIBA 01/2019

Therapy/Procedure

6	Therapeutics 02/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2022 - 10/2021
1	Transplantation 01/2022
1	Drug Tapering 10/2021
1	Spinal Injections 10/2021
1	Oral Administration 12/2020
1	Mediterranean Diet 12/2020
1	Analgesia 01/2020
1	Injections 06/2019